Gyre Therapeutics (GYRE) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Gyre Therapeutics (GYRE) over the last 17 years, with Q3 2025 value amounting to $30.0 million.
- Gyre Therapeutics' Other Gross PP&E Adjustments rose 800.91% to $30.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.0 million, marking a year-over-year increase of 800.91%. This contributed to the annual value of $27.0 million for FY2024, which is 292.45% up from last year.
- Latest data reveals that Gyre Therapeutics reported Other Gross PP&E Adjustments of $30.0 million as of Q3 2025, which was up 800.91% from $29.0 million recorded in Q2 2025.
- Over the past 5 years, Gyre Therapeutics' Other Gross PP&E Adjustments peaked at $30.0 million during Q3 2025, and registered a low of -$3.3 million during Q4 2021.
- Its 5-year average for Other Gross PP&E Adjustments is $12.6 million, with a median of $9.8 million in 2022.
- As far as peak fluctuations go, Gyre Therapeutics' Other Gross PP&E Adjustments crashed by 8716.87% in 2021, and later soared by 16236470.59% in 2024.
- Gyre Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$3.3 million in 2021, then skyrocketed by 703.26% to $19.6 million in 2022, then surged by 33.65% to $26.2 million in 2023, then increased by 2.92% to $27.0 million in 2024, then rose by 11.06% to $30.0 million in 2025.
- Its Other Gross PP&E Adjustments stands at $30.0 million for Q3 2025, versus $29.0 million for Q2 2025 and $29.1 million for Q1 2025.